Skip to main content
SpringerLink
Log in

Imaging of Head and Neck Skin Cancer

  • Chapter
  • First Online:
Skin Cancer Management

  • 1176 Accesses

Abstract

It is important for clinicians to understand and to take advantage of new imaging techniques available for the management of skin cancers. There is little written in either skin cancer or radiology texts on the topic of imaging in head and neck skin cancers. This chapter is an attempt to find a common ground between the disciplines of surgery and radiology so that each may communicate more effectively with the other, thereby benefiting patient care and health-care costs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Beckmann EC. CT scanning the early days. Br J Radiol. 2006;79:5–8.

    Article  CAS  PubMed  Google Scholar 

  2. Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. Am J Roentgenol 2007;188(2):586–592.

    Article  PubMed  Google Scholar 

  3. U.S. Food and Drug Administration. Public health advisory and information for health care professionals: gadolinium-containing contrast agents for magnetic resonance imaging (marketed as Magnevist, Multihance, Omniscan, OptiMARK, Prohance). http://www.fda.gov. Accessed December 15, 2008.

  4. Cowper SE. Nephrogenic Fibrosing Dermopathy [NFD/NSF Website]. 2001–2007. http://www.icnfdr.org. Accessed December 15, 2008.

  5. Shellock FG. Pocket Guide to MR Procedures and Metallic Objects: Update 2001. Philadelphia, PA: Lippincott Williams & Wilkins; 2001.

    Google Scholar 

  6. Nazarian S, Roguin A, Zviman MM, et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation. 2006;114(12):1232–1233.

    Article  Google Scholar 

  7. Parker GD, Harnsberger HR. Clinical-radiologic issues in perineural tumor spread of malignant diseases of the extracranial head and neck. Radiographics. 1991;11(3):383–399.

    Google Scholar 

  8. De Bondt RB, Nelemans PJ, Hofman PA, et al. Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing ultrasound, ultrasound-guided fine needle aspiration, CT and MR imaging. Eur J Radiol. 2007;64(2):266–272.

    Article  PubMed  Google Scholar 

  9. Branstetter BF, Blodgett TM, Zimmer LA, Snyderman CH, Johnson JT, Raman S, Meltzer CC. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 2005;235(2):580–586.

    Article  PubMed  Google Scholar 

  10. Fletcher J, Djulbegovic B, Soares H, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008;49(3):480–508.

    Article  PubMed  Google Scholar 

  11. Even-Sapir E, Lerman H, Lievshitz G, et al. Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. J Nucl Med. 2003;44(9):1413–1420.

    PubMed  Google Scholar 

  12. Kienstra M, Padhya T. Head and neck melanoma. Cancer Control. 2005;12(4):242–247.

    PubMed  Google Scholar 

  13. Leibovitch I, McNab A, Sullivan T, Davis G, Selva D. Orbital invasion by periocular basal cell carcinoma. Ophthalmology. 2005;112(4):717–723.

    Article  PubMed  Google Scholar 

  14. Adams S, Baum R, Stuckensen T, Bitter K, Hör G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med. 1998;25(9):1255–1260.

    Article  CAS  PubMed  Google Scholar 

  15. Wagner J, Evdokimow D, Weisberger E, et al. Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol. 2004;140:75–79.

    Article  PubMed  Google Scholar 

  16. Huang CL, Halpern AC. Management of the patient with melanoma. In: Rigel D, ed. Cancer of the Skin. Philadelphia, PA: Elsevier Saunders; 2005:265.

    Google Scholar 

  17. Pathak I, O’Brien CJ, Petersen-Schaeffer K, et al. Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern? Head Neck. 2001;23(9):785–790.

    Article  CAS  PubMed  Google Scholar 

  18. Kransdorf MJ, Meis-Kindblom JM. Dermatofibrosarcoma protuberans: Radiologic appearance. Am J Roentgenol. 1994;163(2):391–394.

    CAS  Google Scholar 

  19. Torreggiani W, Al-Ismail K, Munk P, Nicolaou S, O’Connell J, Knowling M. Dermatofibrosarcoma protuberans: MR imaging features. Am J Roentgenol. 2002;178:989–993.

    Google Scholar 

  20. Thornton S, Reid J, Papay F, Vidimos A. Childhood dermatofibrosarcoma protuberans: role of preoperative imaging. J Am Acad Dermatol. 2005;53(1):76–83.

    Article  PubMed  Google Scholar 

  21. Medina-Franco H, Urist MM, Fiveash J, Heslin MJ, Bland KI, Beenken SW. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol. 2001;8(3):204–208.

    Article  CAS  PubMed  Google Scholar 

  22. Gupta SG, Wang LC, Peñas PF, Gellenthin M, Lee SJ, Nghiem P. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and review of the literature. Arch Dermatol. 2006;142: 685–690.

    Article  PubMed  Google Scholar 

  23. Yao M, Smith R, Hoffman H, Funk G, Graham M, Buatti J. Merkel cell carcinoma: two case reports focusing on the role of fluorodeoxyglucose positron emission tomography imaging in staging and surveillance. Am J Clin Oncol. 2005;28(2):205–210.

    Article  PubMed  Google Scholar 

  24. Belhocine T, Pierard G, Frühling J, et al. Clinical added-value of 19FDG PET in neuroendocrine-Merkel cell carcinoma. Oncol Rep. 2006;16:347–352.

    PubMed  Google Scholar 

  25. Iagaru A, Quon A, McDougall IR, Gambhir SS. Merkel cell carcinoma: is there a role for 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography? Mol Imaging Biol. 2006;8:212–217.

    Article  CAS  PubMed  Google Scholar 

  26. Durani BK, Klein A, Henze M, Haberkorn U, Hartschuh W. Clinical and laboratory investigations: somatostatin analogue scintigraphy in Merkel cell tumors. Br J Dermatol. 2003;148(6):1135–1140.

    Article  CAS  PubMed  Google Scholar 

  27. Guitera-Rovel P, Lumbroso J, Gautier-Gougis M, et al. Indium-111 octreotide scintigraphy of Merkel cell carcinomas and their metastases. Ann Oncol. 2001;12:807–811.

    Article  CAS  PubMed  Google Scholar 

  28. Shields J, Demirci H, Marr B, Eagle R, Shields C. Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol. 2005;50(2):103–122.

    Article  PubMed  Google Scholar 

  29. Saito A, Tsutsumida A, Furukawa H, Saito N, Yamamoto Y. Sebaceous carcinoma of the eyelids: a review of 21 cases. J Plast Reconstr Aesthet Surg. 2008;61(11):1328–1331.

    Google Scholar 

  30. Husain A, Blumenschein G, Esmaeli B. Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid. Int J Dermatol. 2008;47(3):276–279.

    Article  PubMed  Google Scholar 

  31. Rosai J, Sumner HW, Kostianovsky M, Perez-Mesa C. Angiosarcoma of the skin: a clinicopathologic and fine structural study. Hum Pathol. 1976;7(1):83–109.

    Article  CAS  PubMed  Google Scholar 

  32. Isoda H, Imai M, Inagawa S, Miura K, Sakahara H. Magnetic resonance imaging findings of angiosarcoma of the scalp. J Comput Assist Tomogr. 2005;29(6): 858–862.

    Article  PubMed  Google Scholar 

  33. Hayman L, Shukla V, Ly D, Taber K. Clinical and imaging anatomy of the scalp. J Comput Assist Tomogr. 2003;27(3):454–459.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic Radiology, M.D. Anderson Cancer Center, The University of Texas, Houston, TX, USA

    Komal Shah MD (Assistant Professor)

  2. Department of Diagnostic Radiology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA

    Jane Onufer MD (Assistant Professor)

  3. Departments of Dermatology and Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Deborah F. MacFarlane MD, MPH (Professor)

Authors
  1. Komal Shah MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jane Onufer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Deborah F. MacFarlane MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. One Hermann Museum Circle , Houston, 77004, U.S.A.

    Deborah F. MacFarlane

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Shah, K., Onufer, J., MacFarlane, D.F. (2009). Imaging of Head and Neck Skin Cancer. In: MacFarlane, D.F. (eds) Skin Cancer Management. Springer, New York, NY. https://doi.org/10.1007/978-0-387-88495-0_18

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-88495-0_18

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-88494-3

  • Online ISBN: 978-0-387-88495-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation